{
    "eid": "2-s2.0-85075036916",
    "title": "Understanding of the drug resistance mechanism of hepatitis C virus NS3/4A to paritaprevir due to D168N/Y mutations: A molecular dynamics simulation perspective",
    "cover-date": "2019-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Structural Biology",
            "@code": "1315",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Biochemistry",
            "@code": "1303",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Organic Chemistry",
            "@code": "1605",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Computational Mathematics",
            "@code": "2605",
            "@abbrev": "MATH"
        }
    ],
    "keywords": [
        "D168N",
        "D168Y",
        "HCV NS3/4A protease",
        "Molecular dynamics simulation",
        "Paritaprevir"
    ],
    "authors": [
        "Thitiya Boonma",
        "Bodee Nutho",
        "Thanyada Rungrotmongkol",
        "Nadtanet Nunthaboot"
    ],
    "citedby-count": 4,
    "ref-count": 51,
    "ref-list": [
        "Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study",
        "Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection",
        "Quinoxaline-based linear HCV NS3/4A protease inhibitors exhibit potent activity against drug resistant variants",
        "Hepatitis C virus resistance to protease inhibitors",
        "Hepatitis C virus protease inhibitor-resistance mutations: our experience and review",
        "Biophysical studies on HCV 1a NS3/4A protease and its catalytic triad in wild type and mutants by the in silico approach",
        "Hepatitis C virus NS3/4A protease inhibitors incorporating flexible P2 quinoxalines target drug resistant viral variants",
        "Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease",
        "Molecular and Dynamic Mechanism Underlying Drug Resistance in Genotype 3 Hepatitis C NS3/4A Protease",
        "Treatment of HCV infection with the novel NS3/4A protease inhibitors",
        "Hepatitis C virus NS3/4a protease inhibitors",
        "Molecular mechanism of resistance in a clinically significant double-mutant variant of HCV NS3/4A protease",
        "Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435",
        "Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: Insights from molecular dynamics simulation, binding free energy calculation and network analysis",
        "In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450",
        "Molecular principles behind Boceprevir resistance due to mutations in hepatitis C NS3/4A protease",
        "Exploring resistance mechanisms of HCV NS3/4A protease mutations to MK5172: Insight from molecular dynamics simulations and free energy calculations",
        "The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors",
        "Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target",
        "Amber 14",
        "Gaussian 03",
        "ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB",
        "Development and testing of a general Amber force field",
        "Zinc binding in proteins and solution: a simple but accurate nonbonded representation, Proteins Struct",
        "Potential energy functions for atomic-level simulations ofwater and organic and biomolecular systems",
        "Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems",
        "Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models",
        "Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations",
        "Prediction of binding for a kind of non-peptic HCV NS3 serine protease inhibitors from plants by molecular docking and MM-PBSA method",
        "Effect of halogen substitutions on dUMP to stability of thymidylate synthase/dUMP/mTHF ternary complex using molecular dynamics simulation",
        "Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex",
        "Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1",
        "Harmonic dynamics of proteins: Normal modes and fluctuations in bovine pancreatic trypsin inhibitor (vibrational analysis/protein dynamics/temperature factors/thermodynamic properties/frequency spectrum)",
        "Free energy calculations for theophylline binding to an RNA aptamer: comparison of MM-PBSA and thermodynamic integration methods",
        "Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models",
        "Recent advances in free energy calculations with a combination of molecular mechanics and continuum models",
        "Accurate calculation of hydration free energies using macroscopic solvent models",
        "UCSF Chimera, MODELLER, and IMP: an integrated modeling system",
        "Effect of D168V mutation in NS3/4A HCV protease on susceptibilities of faldaprevir and danoprevir",
        "Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis",
        "Structural analysis of asunaprevir resistance in HCV NS3/4A protease",
        "Exploring the drug resistance of HCV protease",
        "Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models",
        "Exploring protein native states and large-scale conformational changes with a modified generalized born model",
        "Discovery of MK-8831, a novel spiro-proline macrocycle as a pan-genotypic HCV-NS3/4a protease inhibitor",
        "MMPBSA.py: an efficient program for end-state free energy calculations",
        "Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1\u20136 without cirrhosis",
        "Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection",
        "Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors",
        "Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation",
        "Molecular dynamics study on drug resistance mechanism of HCV NS3/4A protease inhibitor: BI201335"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Maha Sarakham",
            "@id": "60002875",
            "affilname": "Mahasarakham University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002875",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Asia Research Center",
        "Center of Excellence for Innovation in Chemistry",
        "Ministry of Higher Education, Science , Research and Innovation",
        "Ministry of Higher Education, Science, Research and Innovation",
        "PERCH-CIC",
        "Chulalongkorn University and the Center of Excellence for Innovation in Chemistry",
        "Chulalongkorn University",
        "National Science and Technology Development Agency",
        "Mahasarakham University"
    ]
}